Evidence map›Paper›PMID 41300177›Full record

ReviewBrain sciences2025

Visual Neurorestoration: An Expert Review of Current Strategies for Restoring Vision in Humans.

Jonathon Cavaleri, Michelle Lin, Kevin Wu, Zachary Gilbert, Connie Huang, Yu Tung Lo, Vahini Garimella, Jonathan C Dallas, Robert G Briggs, Austin J Borja and 4 more

Abstract readReview
In one paragraph

Review in Brain sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jonathon CavaleriDepartment of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA 900033, USA.ORCID 0000-0001-6239-4461
Michelle LinDepartment of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA 900033, USA.
Kevin WuDepartment of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA 900033, USA.
Zachary GilbertDepartment of Ophthalmology, San Antonio Military Medical Center, Lackland, TX 78236, USA.
Connie HuangDepartment of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Yu Tung LoDepartment of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA 900033, USA.ORCID 0000-0002-4234-8991
Vahini GarimellaDepartment of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Jonathan C DallasDepartment of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA 900033, USA.ORCID 0000-0003-0202-2003
Robert G BriggsDepartment of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA 900033, USA.
Austin J BorjaDepartment of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA 900033, USA.
Jae Eun LeeDepartment of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA 900033, USA.
Patrick R NgDepartment of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA 900033, USA.ORCID 0000-0003-4566-9173
Kimberly K GokoffskiDepartment of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Darrin J LeeDepartment of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA 900033, USA.

Funding

ARPA-H 75N99224R0002Department of Defense W81XWH-22-1-0743NEI NIH HHS R01EY035375, R01EY035715
6 · The paper itself

Abstract

Visual impairment impacts nearly half a billion people globally. Corrective glasses, artificial lens replacement, and medical management have markedly improved the management of diseases inherent to the eye, such as refractive errors, cataracts, and glaucoma. However, therapeutic strategies for retinopathies, optic nerve damage, and distal optic pathways remain limited. The complex optic apparatus comprises multiple neural structures that transmit information from the retina to the diencephalon to the cortex. Over the last few decades, innovations have emerged to address the loss of function at each step of this pathway. Given the retina's lack of regenerative potential, novel treatment options have focused on replacing lost retinal cell types through cellular replacement with stem cells, restoring lost gene function with genetic engineering, and imparting new light sensation capabilities with optogenetics. Additionally, retinal neuroprosthetics have shown efficacy in restoring functional vision, and neuroprosthetic devices targeting the optic nerve, thalamus, and cortex are in early stages of development. Non-invasive neuromodulation has also shown some promise in modulating the visual cortex. Recently, the first in-human whole-eye transplant was performed. While functional vision was not restored, the feasibility of such a transplant with viable tissue graft at one year was demonstrated. Subsequent studies are now focused on guidance cues for axonal regeneration past the graft site to reach the lateral geniculate nucleus. Although the methods discussed above have shown promise individually, improvements in vision have been modest at best. Achieving the goal of restoration of functional vision will clearly require further development of cellular therapies, genetic engineering, transplantation, and neuromodulation. A concerted multidisciplinary effort involving scientists, engineers, ophthalmologists, neurosurgeons, and reconstructive surgeons will be necessary to restore vision for patients with vision loss from these challenging pathologies. In this expert review article, we describe the current literature in visual neurorestoration with respect to cellular therapeutics, genetic therapies, optogenetics, neuroprosthetics, non-invasive neuromodulation, and whole-eye transplant.

Indexed as

blindnesseye transplantgenetic engineeringneuromodulationoptogeneticsstem cell therapyvisual impairment

Identifiers

PMID41300177
PMCPMC12650385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.